Religare Enterprises Limited

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about the allotment of equity shares by its wholly owned subsidiary, Religare Broking Limited, in its rights issue. The allotment was made at a premium of INR 13.75 and the total amount raised was INR 100,00,00,020. The proceeds will be utilized in the general business operations of the company, including scaling up margin trade financing book and working capital requirement.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about Transcript of earnings call held on Thursday, August 13, 2026 at 04.00 P.M. IST. The transcript has been made available on the website of the Company at https://docs.religare.com/pdf/Religare_Enterprises_Limited_Q1_FY_27_13_Aug_2026.pdf.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about a special window for transfer and dematerialisation of physical securities, which were sold/purchased prior to April 1, 2019. The special window is open from February 5, 2026, to February 4, 2027.

Religare Enterprises Limited

Religare Enterprises Limited has made available the audio recording of its earnings call held on August 13, 2026, to discuss its operational and financial performance for the quarter ended June 30, 2026.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about the publication of un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved by the Board of Directors in their meeting held on August 12, 2026, and were published on the stock exchange on the same day.

Religare Enterprises Limited

Religare Enterprises Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, issued by CARE Ratings Limited, Monitoring Agency, in respect of the utilization of proceeds raised through Preferential Issue of convertible warrants.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about an investor presentation for the Q1 FY2027 earnings call, which will be held on August 13, 2026.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about General Updates, specifically the outcome of the Board of Directors meeting where they considered and approved the Un-Audited Standalone Financial Statements for the quarter ended June 30, 2026, along with financial results prepared under Regulation 33 of the SEBI Listing Regulations. The company has also disclosed ongoing income tax litigations and related tax demands in Note 10 to the Statement.

Religare Enterprises Limited

Religare Enterprises Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with the company's board of directors approving the results and re-designating Mr. Arjun Lamba as Managing Director.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange regarding the appointment of Mr Arjun Lamba as Managing Director of the company effective August 12, 2026. The Board of Directors also approved the un-audited financial results for the quarter ended June 30, 2026, and re-designated Mr. Arjun Lamba as Managing Director.

Religare Enterprises Limited

Religare Enterprises Limited has submitted its financial results for the quarter ended June 30, 2026, and approved the re-designation of Mr. Arjun Lamba as Managing Director.

Religare Enterprises Limited

Religare Enterprises Limited has amended its 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' in compliance with Regulation 8(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about the grant of 13,195 stock options to eligible employees under the Religare Enterprises Limited Employee Stock Option Plan 2019.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about a scheduled earnings call to discuss the operational & financial performance of the Company for quarter ended June 30, 2026.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about non-approval of the Scheme of Arrangement involving transfer of the Demerged Undertaking to Religare Finvest Limited by the Reserve Bank of India.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about an update on the demerger scheme involving the transfer of the demerged undertaking to Religare Finvest Limited, but the RBI has not given its no-objection/prior approval for the scheme.

Religare Enterprises Limited

Religare Enterprises' subsidiary, Care Health Insurance, has issued 20,000 debentures worth Rs. 200 Crore at a 10% interest rate, listed on NSE's debt segment.

Religare Enterprises Limited

Religare Enterprises Limited has allotted 3.5 million equity shares following the conversion of warrants at its meeting on August 6, 2026.

Religare Enterprises Limited

Religare Enterprises Limited has informed the Exchange about General Update on announcements dated February 26, 2025 and May 12, 2026, regarding the approval of voluntary surrender of MIC's Licence as Insurance Web Aggregator by IRDAI.

Religare Enterprises Limited

Religare Enterprises Limited has received an order from SEBI disposing off an interim order cum show cause notice issued against the company and its board of directors without any directions.